On Wednesday 5 February, 2025, Teltow, Germany – The EU-funded micro2MACRO (m2M) project, which launched in December 2024, is set to advance tissue regeneration through a groundbreaking bioprinting platform. m2M has a clear goal of precisely patterning cell aggregates and microtissues into stable, customizable grafts that can remodel into fully functional tissues after implantation.
